Skip to main content

Table 2 Trial flow chart

From: TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial

  Screening Enrollment Every 4 weeks for 1st 24 weeks, then every 12 weeks Additional evaluations every 24 weeks Final study visit, time of termination Premature discontinuation of study treatment Unscheduled Visits
Informed consent       
Review of past medical history       
Review of current complaints   
Medication history    
Bednet use    
WHO performance scale    
Complete blood count, alanine aminotransferase, creatinine    
Urine pregnancy test a a     
CD4 count    
HIV viral load    
Filter paper sample    
Physical examination √ (limited) √ (limited)
Visual acuity assessment    
Provision of medication      
Pill count and adherence interview     
  1. aUrine pregnancy testing will be performed at all study visits only where pregnancy is suspected